Treatment of insulin resistanceInsulin resistance, including the cunning hydrangea tea extract, obesity, The present invention relates to hyperlipidemia treatment composition and weight loss. [Selection] Figure Figure 1ホ テリンソン ヘボックパク ドンチャンファン シャンラク...
TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED 专利名称：TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION 发明人：HOTAMISLIGIL, Gökhan, S.,SIEGELMAN, Bruce, M.申请号：US1993009830 申请日：19931014 公开号：WO94/008609P1 公开日：19940428 ...
Biochemical definition of a low plasma glucose: – 3.0 mmol/L (<54.1 mg/dL) (EMA)1 – 3.9 mmol/L (≤70 mg/dL) (ADA)2 – 4.0 mmol/L (<72 mg/dL) for clinical use in patients treated with insulin or an insulin secretagogue (CDA)3 ADA, American Diabetes Association; CDA, ...
Method for treatment of insulin resistanceA screening method for identifying compositions which affect the binding of protein tyrosine phosphatase 1B (PTP1B) to phosphorylated insulin receptor is provided. This method measures a composition's ability to inhibit binding of PTP1B to the &bgr;-subunit...
Insulin resistance, defined as an attenuated or inadequate response to a given amount of insulin, is associated with a wide variety of conditions including obesity, type 2 diabetes, essential hypertension, cardiovascular disease, polycystic ovary syndrome, non-alcoholic fatty liver, breast cancer, and...
Two cases of insulin resistance are described, and recent developments in the pathogenesis and treatment of insulin resistance are reviewed. Both immune and nonimmune types of insulin resistance have been described. Immune resistance is related to the presence of circulating antibodies directed against ...
Peroxisome proliferator-activated receptor gamma (PPARgamma) is a clinically validated target for treatment of insulin resistance. PPARgamma activation by ... LS Higgins,AM Depaoli - 《American Journal of Clinical Nutrition》 被引量: 191发表: 2010年 Physiological and Therapeutic Roles of Peroxisome ...
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 来自 FreePatentsOnline 喜欢 0 阅读量: 26 作者: JA Butera,CE Caufield,RF Graceffa,A Greenfield,EG Gundersen,LM Havran,AH Katz,JR Lennox,SC Mayer,RE Mcdevitt 展开 摘要: B, D, C, and R 1 as ...
摘要: This invention provides compounds of Formula I having the structurewherein:B, C, D, and R1 are as defined hereinbefore in the specification, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia....
2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemiaThis invention provides compounds of Formula I having the structure... JA Butera,JR Lennox,RE Mcdevitt,... 被引量...